PortfoliosLab logoPortfoliosLab logo

Invenomic Fund (BIVRX) Alternatives

Invenomic Fund (BIVRX) belongs to the Long-Short category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with BIVRX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to BIVRX

BIVRX charges 2.48% annually. Among mutual funds in the Long-Short category, these options have the lowest expense ratios among BIVRX alternatives.


Best Risk-Adjusted Alternatives to BIVRX

Among mutual funds in the Long-Short category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing BIVRX Alternatives (YTD)

BIVRX alternatives from the Long-Short category, sorted by year-to-date return.


Lowest Volatility Alternatives to BIVRX

BIVRX alternatives from the Long-Short category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to BIVRX

BIVRX alternatives from the Long-Short category, sorted by maximum drawdown over the past year.


Other Mutual Funds from Invenomic

Most popular Invenomic mutual funds on PortfoliosLab, across asset classes.


SymbolNameCategoryRisk / Return RankYTD ReturnInception
Invenomic Fund Institutional ClassLong-Short
7
3.73%
Jun 19, 2017BIVRX vs BIVIX

Often Compared With BIVRX

What investors most often compare with BIVRX, based on PortfoliosLab usage data.


Compare BIVRX with Any Fund or Stock

Compare BIVRX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


Invenomic Fund